Shree Ram Proteins Board Approves Sale of Undertaking for ₹17 Crore
Shree Ram Proteins Limited's Board approved the sale of substantially the whole undertaking for ₹17 Crore. Shareholder approval will be sought via Postal Ballot. Ms. Payal Dhamecha appointed as Scrutinizer.
The sale of substantially the whole undertaking of the company is a major strategic decision that will fundamentally alter the company's operations and asset base, thus having a high impact.
The announcement details a significant corporate action (sale of undertaking) and a board meeting outcome. While the sale itself is material, the sentiment is neutral as it's a proposal requiring further shareholder and regulatory approvals, and the direct financial impact on profitability isn't immediately clear from this announcement.
Shree Ram Proteins Limited's Board of Directors, in a meeting held on August 10, 2026, has approved the proposal for the sale or transfer of the whole or substantially the whole of the company's undertaking. This significant transaction is proposed for an aggregate consideration of approximately ₹17.00 Crore.
To facilitate this sale, the Board has also approved the Postal Ballot Notice and established a calendar of events for obtaining shareholder approval through a Special Resolution via Postal Ballot. Furthermore, Ms. Payal Dhamecha, a Practicing Company Secretary, has been appointed as the Scrutinizer to oversee the Postal Ballot process, ensuring fair and transparent remote e-voting.
The meeting commenced at 12:20 P.M. and concluded at 12:50 P.M. at the company's registered office in Rajkot, Gujarat. All other agenda items were also considered and approved.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.